NOGGO S19 - EXPRESSION VIII (8)
For patients with a low-grade ovarian carcinoma (group A) or a borderline tumor of the ovary (group B – closed).
Serous ovarian carcinoma is classified into a well-differentiated (low-grade) tumor and a low-differentiated (high-grade) tumor. The low-grade tumor accounts for only about 10% of ovarian carcinomas and is associated with a better prognosis compared to the high-grade tumor. Despite the good prognosis, there is a great need for information for and about this patient group.
What is the aim of this survey?
As part of the survey “EXPRESSION VIII – Individual perception and level of information of patients with low-grade ovarian cancer or a borderline tumor of the ovary”, we would like to learn from you in order to improve patient education about the disease and therapy and thus increase the level of information of patients.
How exactly does the survey work?
You will receive various paper questionnaires to complete. By completing the questionnaire or answering the questions, you agree to take part in the survey and confirm that you are fully informed about the survey and understand its objectives. We have deliberately limited the number of questions in order to keep the effort for you as low as possible. We do not require your name, address or date of birth to participate. The survey is anonymous. Completing the questionnaire will take about 20-30 minutes of your time. Please return the completed questionnaire to the person who gave you the survey or send it back to the address given in the questionnaire.
Are there any risks?
No, this is a survey.
Participation requirements
Women aged 18 and over can take part in this study.
- Women aged 18 and over can take part in this study.
- Patients with low-grade serous tubal, peritoneal or ovarian cancer.
- Initial treatment, recurrences possible.
Group B for patients with a borderline tumor of the ovary is closed, as numerous patients have already taken part in the survey. We look forward to the upcoming study results!
Where can I participate in the study?
Patients can take part via the participating centers. It is not possible to answer the questions in this survey via the Internet.
